## **Core Concept**
The question tests the understanding of drug metabolism and its implications in patients with hepatic disease. Certain drugs are metabolized by the liver, and in cases of hepatic disease, their metabolism can be significantly affected, leading to potential toxicity.

## **Why the Correct Answer is Right**
The correct answer, , is likely a drug that is primarily metabolized by the liver. Drugs that are extensively metabolized by the liver can accumulate to toxic levels in patients with hepatic disease, leading to increased risk of adverse effects. For instance, drugs like **warfarin**, which is metabolized by the cytochrome P450 system in the liver, require dose adjustments in patients with liver disease to prevent bleeding complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** If is primarily excreted unchanged by the kidneys, its levels would be more affected by renal disease rather than hepatic disease.
- **Option B:** Similarly, if is not significantly metabolized by the liver or has a wide therapeutic window, it might not require dose adjustments in hepatic disease.
- **Option C:** This option might seem plausible but is incorrect based on the specifics of drug metabolism and the context of the question.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in patients with hepatic disease, drugs that are primarily metabolized by the liver should be used with caution, and dose adjustments may be necessary to prevent toxicity. A classic example is **metformin**, but more so, drugs like **statins** and **warfarin** require careful monitoring.

## **Correct Answer:** .